Eisai

4523.TSE

29.89 USD

-0.20

-0.66%

Overview

Last close

29.89 usd

Market cap

8.43B usd

52 week high

43.43 usd

52 week low

24.09 usd

Target price

31.42 usd

Valuation

P/E

26.6594

Forward P/E

32.6797

Price/Sales

1.6354

Price/Book Value

1.5528

Enterprise Value

8.09B usd

EV/Revenue

1.5681

EV/EBITDA

11.4596

Key financials

Revenue TTM

5.16B usd

Gross Profit TTM

4.04B usd

EBITDA TTM

596.75M usd

Earnings per Share

1.12 usd

Dividend

1.03 usd

Total assets

9.73B usd

Net debt

-439.51M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.